Yuzuru Kanakura
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 136 publications
Efficacy of ciclosporin monotherapy in non-severe aplastic anaemia not requiring transfusions: Results from a multicentre phase II study.
Journal: British journal of haematology
Published: April 18, 2025
Treatment burden in patients with paroxysmal nocturnal hemoglobinuria: an in-depth interview survey.
Treatment burden in patients with paroxysmal nocturnal hemoglobinuria: an in-depth interview survey.
Journal: Annals of hematology
Published: March 26, 2025
Prevention and Management of Thromboembolism in Patients with Paroxysmal Nocturnal Hemoglobinuria in Asia: A Narrative Review.
Journal: International journal of molecular sciences
Published: January 23, 2025
Monitoring and Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia in Asia: An Expert Consensus.
Journal: International journal of molecular sciences
Published: October 21, 2024
End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan hematology Study Group (W-JHS) NHL01 trial.
Journal: International journal of hematology
Published: September 06, 2023
Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
Journal: Japanese journal of clinical oncology
Published: June 19, 2023
A longitudinal analysis of paroxysmal nocturnal haemoglobinuria-type cells in patients with bone marrow failure: Results of a prospective multi-centre study in Japan.
Journal: British journal of haematology
Published: April 26, 2023
Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum.
Journal: International journal of hematology
Published: April 04, 2023
Dose-escalation part of Phase I study of single-agent mosunetuzumab in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma.
Journal: Japanese journal of clinical oncology
Published: March 23, 2023
Mitigating Drug-Target-Drug Complexes in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Switch C5 Inhibitors.
Journal: Clinical pharmacology and therapeutics
Published: September 26, 2022
ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial.
Journal: International journal of hematology
Published: April 28, 2022
Last Updated: 09/26/2026